Described are simplified and efficient methods for preparing recombinant
adenovirus using liposome-mediated cotransfection and the direct
observation of a cytopathic effect (CPE) in the transfected cells. Also
disclosed are compositions and methods involving novel p53 adenovirus
constructs, including methods for restoring p53 function and tumor
suppression in cells and animals having abnormal p53.
